Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022

BUY
$32.4 - $68.18 $2.19 Million - $4.6 Million
67,468 Added 35.83%
255,749 $17.4 Million
Q2 2022

Jul 29, 2022

SELL
$22.3 - $37.39 $1.74 Million - $2.93 Million
-78,233 Reduced 29.35%
188,281 $6.02 Million
Q1 2022

Apr 27, 2022

BUY
$25.68 - $35.59 $6.84 Million - $9.49 Million
266,514 New
266,514 $9.23 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Mizuho Markets Americas LLC Portfolio

Follow Mizuho Markets Americas LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Markets Americas LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Markets Americas LLC with notifications on news.